Agilent Introduces Groundbreaking UV-Vis Spectrophotometer for Pharmaceutical, Biomedical, and Academic Laboratories

Agilent Introduces Groundbreaking UV-Vis Spectrophotometer for Pharmaceutical, Biomedical, and Academic Laboratories Cary 3500 UV-Vis system can run multiple experiments simultaneously, boosting laboratory efficiency SANTA CLARA, Calif., November 1, 2018 Agilent Technologies Inc. (NYSE: A) today introduced the Cary 3500 UV-Vis system, an innovative spectrophotometer designed to help life science, pharma and biopharma research communities simplify... Read more

Next Generation FluidScan® Portable Oil Analyzer From Spectro Scientific Features Upgraded Electronics, Software, Memory and Ergonomics

October 31, 2018 Spectro Scientific, one of the world’s largest suppliers of oil, fuel, and processed-water analysis instrumentation and software, has released a new generation of its field-proven FluidScan® mid-infrared spectrometer handheld oil analyzer. Patented FluidScan technology collects light transmitted through one drop of a fluid sample and registers the infrared absorption spectrum. The analyzer compares spectrum data to... Read more

Bruker Launches the S2 POLAR™ High-Performance, Multi-Element Benchtop EDXRF Analyzer for the Petrochemical Industry

GALVESTON, Texas, Oct. 16, 2018 /PRNewswire/ — At the Gulf Coast Conference, Bruker announces the launch of the S2 POLAR™, a new multi-element benchtop analyzer based on polarized Energy Dispersive X-Ray Fluorescence (EDXRF). The S2 POLAR offers the same excellent analytical precision for quality control in the petrochemical industry, which is typically only achieved by more... Read more

QIAGEN’s next-generation QIAstat-Dx system delivers fast, cost-effective diagnosis of gastrointestinal syndromes

Hilden, Germany, and Germantown, Maryland, October 15, 2018– QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the European rollout of its next-generation QIAstat-Dx panel for one-step, fully integrated molecular analysis of gastrointestinal (GI) syndromes. The multiplex gastrointestinal panel, which QIAGEN has upgraded to now include comprehensive viral coverage  detects the 24 most common viral,... Read more

PerkinElmer Receives FDA Clearance for NeoBase™ 2 Non-Derivatized Tandem Mass Spectrometry Kit

In vitro diagnostic solution tests newborn babies for a variety of metabolic disorders with a single dried blood spot card WHAT: PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that its NeoBase™ 2 Non-Derivatized MSMS Kit has received 510(k) clearance from the U.S. Food & Drug Administration (FDA). Used with... Read more

MTS Designs Sophisticated Simulator To Help Protect Underground Utilities And Pipelines

EDEN PRAIRIE, Minn., Sept. 25, 2018 /PRNewswire/ — MTS Systems Corporation (NASDAQ: MTSC), a leading global supplier of high-performance test systems and sensors, today announced the development of a unique soil-structures interaction simulator that will help protect underground infrastructure from catastrophic damage. This first-of-a-kind system will be built in the new National Buried Infrastructure Facility (NBIF)... Read more

University Liège becomes labs@location Partner for ZEISS

Providing in depth knowledge and dedicated services Customer Story GeMMe at University Liège, Belgium is now a labs@location partner of ZEISS. GeMMe laboratories are dedicated to research as well as providing analytical services for industrial partners in the following specialties: Building Materials, Mineral Processing, Recycling & Hydrometallurgy and Sensor Based Sorting and Characterization. They are well... Read more

FDA approves subcutaneous formulation of Actemra for use in active systemic juvenile idiopathic arthritis (sJIA), a rare form of juvenile arthritis

Basel, 13 September 2018 FDA approves subcutaneous formulation of Actemra for use in active systemic juvenile idiopathic arthritis (sJIA), a rare form of juvenile arthritis Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has approved the subcutaneous (SC) formulation of Actemra® (tocilizumab) for the treatment of active... Read more